Detalhe da pesquisa
1.
A Randomized, Double-blind, Multicenter Trial Comparing Efficacy and Safety of Imipenem/Cilastatin/Relebactam Versus Piperacillin/Tazobactam in Adults With Hospital-acquired or Ventilator-associated Bacterial Pneumonia (RESTORE-IMI 2 Study).
Clin Infect Dis
; 73(11): e4539-e4548, 2021 12 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-32785589
2.
A Mortality Analysis of Letermovir Prophylaxis for Cytomegalovirus (CMV) in CMV-seropositive Recipients of Allogeneic Hematopoietic Cell Transplantation.
Clin Infect Dis
; 70(8): 1525-1533, 2020 04 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-31179485
3.
RESTORE-IMI 1: A Multicenter, Randomized, Double-blind Trial Comparing Efficacy and Safety of Imipenem/Relebactam vs Colistin Plus Imipenem in Patients With Imipenem-nonsusceptible Bacterial Infections.
Clin Infect Dis
; 70(9): 1799-1808, 2020 04 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-31400759
4.
Bezlotoxumab for Prevention of Recurrent Clostridium difficile Infection.
N Engl J Med
; 376(4): 305-317, 2017 01 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-28121498
5.
Letermovir Prophylaxis for Cytomegalovirus in Hematopoietic-Cell Transplantation.
N Engl J Med
; 377(25): 2433-2444, 2017 12 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-29211658
6.
A randomized, double-blind trial investigating the efficacy of caspofungin versus amphotericin B deoxycholate in the treatment of invasive candidiasis in neonates and infants younger than 3 months of age.
J Antimicrob Chemother
; 75(1): 215-220, 2020 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31586424
7.
Prospective, randomized, double-blind, Phase 2 dose-ranging study comparing efficacy and safety of imipenem/cilastatin plus relebactam with imipenem/cilastatin alone in patients with complicated urinary tract infections.
J Antimicrob Chemother
; 72(9): 2616-2626, 2017 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28575389
8.
Pharmacokinetics and safety results from the Phase 3 randomized, open-label, study of intravenous posaconazole in patients at risk of invasive fungal disease.
J Antimicrob Chemother
; 72(12): 3406-3413, 2017 Dec 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28961714
9.
Phase 2, Dose-Ranging Study of Relebactam with Imipenem-Cilastatin in Subjects with Complicated Intra-abdominal Infection.
Antimicrob Agents Chemother
; 60(10): 6234-43, 2016 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-27503659
10.
Phase 3 pharmacokinetics and safety study of a posaconazole tablet formulation in patients at risk for invasive fungal disease.
J Antimicrob Chemother
; 71(3): 718-26, 2016 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-26612870
11.
Pharmacokinetics, efficacy, and safety of caspofungin in Japanese pediatric patients with invasive candidiasis and invasive aspergillosis.
J Infect Chemother
; 21(6): 421-6, 2015 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-25701307
12.
Phase 1B study of the pharmacokinetics and safety of posaconazole intravenous solution in patients at risk for invasive fungal disease.
Antimicrob Agents Chemother
; 58(7): 3610-7, 2014 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-24733463
13.
Phase 1b study of new posaconazole tablet for prevention of invasive fungal infections in high-risk patients with neutropenia.
Antimicrob Agents Chemother
; 58(10): 5758-65, 2014 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-25049247
14.
Effect of an investigational vaccine for preventing Staphylococcus aureus infections after cardiothoracic surgery: a randomized trial.
JAMA
; 309(13): 1368-78, 2013 Apr 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-23549582
15.
Pharmacokinetics and safety results from the Phase 3 randomized, open-label, study of intravenous posaconazole in patients at risk of invasive fungal disease.
J Antimicrob Chemother
; 72(12): 3501, 2017 12 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29029280
16.
Population pharmacokinetics and pharmacodynamics of caspofungin in pediatric patients.
Antimicrob Agents Chemother
; 55(5): 2098-105, 2011 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-21300834
17.
Phase 3 pharmacokinetics and safety study of a posaconazole tablet formulation in patients at risk for invasive fungal disease.
J Antimicrob Chemother
; 71(6): 1747, 2016 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-26960721
18.
Efficacy and safety of caspofungin in obese patients.
Med Mycol
; 49(7): 748-54, 2011 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-21466264
19.
Caspofungin use in patients with invasive candidiasis caused by common non-albicans Candida species: review of the caspofungin database.
Antimicrob Agents Chemother
; 54(5): 1864-71, 2010 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-20231388
20.
A Multicenter, double-blind trial of a high-dose caspofungin treatment regimen versus a standard caspofungin treatment regimen for adult patients with invasive candidiasis.
Clin Infect Dis
; 48(12): 1676-84, 2009 Jun 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-19419331